Clinical Trial Update: Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating prevention and treatment of chemotherapy-induced peripheral neuropathy in advanced colorectal cancer; study terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Colorectal Cancer

Drugs mentioned

• Pfizer Upjohn/Merger with Mylan Viatris product

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Chemotherapy-Induced Peripheral Neuropathy | Phase 4 | Status: TERMINATED | Results posted: 2009-04-17